SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Despite NVIDIA reporting record-breaking earnings and strong guidance, the stock is seeing a notable post-earnings pullback, sparking community debate about "sell the news" dynamics, market manipulation, and the impact on options.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is surging following a surprisingly profitable earnings report that showcased strong expense management and a significantly improved outlook, alongside multiple new Material Transfer Agreements including a key oncology focus for its Matrix-M adjuvant, igniting fervent short-squeeze chatter and long-term buyout speculation among the community.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is experiencing a significant sell-off following a substantial earnings miss and reduced 2026 revenue guidance, triggering widespread investor frustration over perceived management credibility issues. Despite the sharp drop, a segment of the community sees this as an overreaction and a compelling long-term buying opportunity within the growing energy storage sector.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending after weak Q1 guidance overshadowed a Q4 earnings beat, leading to a sharp sell-off and analyst downgrades. The community is fiercely debating whether this represents an oversold 'bargain' given strong fundamentals and a new buyback program, or if decelerating growth and competitive concerns signal further downside.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is rallying sharply following a strong earnings beat, robust revenue growth, and key announcements including a major quantum-secure network deployment in Europe and a significant defense contract. The community is actively debating if current momentum, fueled by short-squeeze potential and strategic wins, can overcome persistent valuation concerns in the evolving quantum computing sector.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is drawing significant community attention ahead of its earnings, with optimism stemming from its vital role in AI infrastructure through custom ASICs and networking, along with projections for doubling AI revenue and substantial chip sales by 2027. This bullish outlook contrasts with some investors' anxieties over broader market movements and potential margin impacts.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the market processes NVDA's strong earnings through a "sell the news" dynamic, prompting community conversations around predictable intraday "V-shape" recoveries and a potential shift of capital into the software sector.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix Corp is a hot topic following its earnings report, revealing a significant smart eyewear purchase order that excites many, while ongoing delays in achieving high-volume smartphone commercialization and persistent yield challenges fuel debate over management's execution. The community is weighing the groundbreaking potential of its silicon-anode battery technology against prolonged timelines and comparisons to struggling peers.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as its solid earnings and a substantial $50 billion share buyback program overshadow the market's initial negative reaction to conservative guidance. Community sentiment highlights a potential rotation from chip stocks to software, reinforced by arguments that AI will enhance, not replace, enterprise software, making CRM an attractive, undervalued play.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending following a significant Q4 earnings beat and positive commentary at the CAGNY conference, which detailed substantial distribution and shelf space expansion for its brands, including Alani Nu, through the PepsiCo partnership. The community is enthusiastically anticipating a continued rally driven by market share gains, although some shareholders express concerns about management's strategic decisions and speculate on a potential, lower-valued PepsiCo acquisition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GNPX Everyone is asking why Tim Moore is buying a micro-cap gene therapy stock like GNPX.

Tim Moore is a fiscal hawk. His job is to cut government spending.
Chronic diseases like Diabetes are the number one drain on Medicare and Medicaid. They cost the US billions every year in lifetime care.
Gene Therapy is a one and done cure. It eliminates the lifetime cost.

He isn&#39;t just betting on science. He is betting on the only deflationary technology that can actually save the federal budget.
Cures are cheaper than care. That is the Budget Committee play.

$GNPX https://www.webullapp.co.uk/news-detail/14441155192349696?theme=1&amp;hl=en&amp;color=2&amp;_v=1&amp;tickerId=950052394&amp;disSymbol=GNPX&amp;sourcePage=Stock_NewsList&amp;sp=0&amp;hl=en

Webull provides you with timely and quality global financial news

Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying

StockTwits for iOS

Genprex Inc

StockCaptain7

$GNPX Don&#39;t Forget Where He&#39;s From
People think Tim Moore is just guessing on GNPX. They forget he spent a decade leading North Carolina, which is a top 3 global biotech hub.
He knows the regulatory binary and FDA phases better than 99% of Congress because his home state&#39;s economy is built on it.
When a politician from a biotech stronghold starts loading a specific micro-cap 3 times in 5 months, it is not a gamble. It is an educated bet on the home team&#39;s sector.

 Everyone is asking why Tim Moore is buying a micro-cap gene therapy stock like GNPX.

Tim Moore is a fiscal hawk. His job is to cut government spending.
Chronic diseases like Diabetes are the number one drain on Medicare and Medicaid. They cost the US billions every year in lifetime care.
Gene Therapy is a one and done cure. It eliminates the lifetime cost.

He isn't just betting on science. He is betting on the only deflationary technology that can actually save the federal budget.
Cures are cheaper than care. That is the Budget Committee play.